The amount of boron accumulated in tumor tissue plays an important role regarding the
success of the boron neutron capture therapy (BNCT). In this article, we report a modular system,
combining readily available starting materials, like glycine, 1,3,5-triazine and the well-known
9-mercapto-1,7-dicarba-closo-dodecaborane(12), as well as alpha-d-galactopyranose for increased
hydrophilicity, with a novel boron-rich tris-meta-carboranyl thiol.
Identifer | oai:union.ndltd.org:DRESDEN/oai:qucosa:de:qucosa:84653 |
Date | 11 April 2023 |
Creators | Kellert, Martin, Lönnecke, Peter, Riedl, Bernd, Koebberling, Johannes, Hey-Hawkins, Evamarie |
Publisher | MDPI |
Source Sets | Hochschulschriftenserver (HSSS) der SLUB Dresden |
Language | English |
Detected Language | English |
Type | info:eu-repo/semantics/publishedVersion, doc-type:article, info:eu-repo/semantics/article, doc-type:Text |
Rights | info:eu-repo/semantics/openAccess |
Relation | 1420-3049, 3288 |
Page generated in 0.0026 seconds